Addressing these questions will enhance our understanding of LIM proteins in general and ABLIM1 in particular in normal physiology and cancer biology, providing valuable insights for future research and guiding precision medicine approaches for cancer treatment that ultimately improve patient outcomes. This evidence concerns the gene ABLIM1 and cancer.